Categories: News

Highlights from Day 3 of CoinGeek Zurich

LONDON, June 10, 2021 /PRNewswire/ — The third day of CoinGeek’s Zurich Conference 2021 featured 3rd party numerical, confirmation that BSV is tangibly greener than BTC and a robust debate between Bitcoin sceptics Nassim Nicholas Taleb, Nouriel Roubini and Dr Craig Wright. The day also saw SEBA Bank, Germany’s SNGLR Group and IBM Global Business Services discussing how banking and digital assets can work together rather than be viewed as rivals.

Here is a quick summary of what happened earlier today:

  • Australia’s Predict Ecology MD Daniel Keane highlighted, pictorially, the ecological difference between BTC and BSV, namely: BSV 30 tonnes CO2/100,000 transactions. BTC 10,810 tonnes CO2/100,000 transactions
  • Dr Daniel Demus announces the launch of the non-profit Swiss Open Wealth Association to help modernise the private banking sector while he and IBM’s Marc Geiger agree that the banking sector have a ‘fundamental data problem’
  • Roubini and Taleb see BTC lack of scalability as rendering it useless. BSV showcased that it can handle 50,000 transactions per second

CoinGeek Zurich is powered by Ayre Ventures and kindly sponsored by: Bitcoin Association, Boquan, Cozen O’Connor, EHR Data, Fabriik, nChain, Ontier, TAAL and Vaionex.

Viewers can enjoy all 3 days of the conference in replay. If they would like to see the sparks fly between Roubini, Taleb, Wright and Grigg, head here.

View original content:http://www.prnewswire.com/news-releases/highlights-from-day-3-of-coingeek-zurich-301310309.html

SOURCE CoinGeek

Staff

Recent Posts

Izotropic Corporation Announces Closing of First Tranche of Non-Brokered Private Placement

Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE:…

2 hours ago

Akanda Corporation Announces Completion of F-3 Shelf Registration Statement

London, United Kingdom--(Newsfile Corp. - June 14, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…

2 hours ago

Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company, today…

3 hours ago

Justera Health Signs LOI to Acquire Popular Cannabis Brand Port North

Toronto, Ontario--(Newsfile Corp. - June 14, 2024) - Justera Health Ltd. (CSE: VTAL) (OTC Pink:…

3 hours ago

OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data License Agreement

Partner’s software products and services are utilized by hundreds of life science organizations, including the…

3 hours ago

Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis

MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits disease progression, pro-inflammatory cytokines and autoantibody production…

3 hours ago